prednisone has been researched along with Bladder Cancer in 39 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Excerpt | Relevance | Reference |
---|---|---|
"Studies have suggested a positive association between bladder cancer (BC) outcome and comedication use, including nonsteroidal anti-inflammatory drugs (NSAID), metformin, and prednisone use." | 8.31 | Chronic prednisone, metformin, and nonsteroidal anti-inflammatory drug use and clinical outcome in a cohort of bladder cancer patients undergoing radical cystectomy in Québec, Canada. ( Aprikian, AG; Dragomir, A; Kassouf, W; O'Flaherty, A; Tanguay, S; Wissing, MD, 2023) |
"Corticosterone and prednisone are suggested to have the potential of being harmless, in contrast to dexamethasone, without promoting cell proliferation or inhibiting cytotoxic activity of cisplatin, yet beneficial to bladder cancer patients via suppressing tumor invasion." | 7.80 | Differential regulation of bladder cancer growth by various glucocorticoids: corticosterone and prednisone inhibit cell invasion without promoting cell proliferation or reducing cisplatin cytotoxicity. ( Ishiguro, H; Kashiwagi, E; Kawahara, T; Li, Y; Miyamoto, H; Zheng, Y, 2014) |
"Studies have suggested a positive association between bladder cancer (BC) outcome and comedication use, including nonsteroidal anti-inflammatory drugs (NSAID), metformin, and prednisone use." | 4.31 | Chronic prednisone, metformin, and nonsteroidal anti-inflammatory drug use and clinical outcome in a cohort of bladder cancer patients undergoing radical cystectomy in Québec, Canada. ( Aprikian, AG; Dragomir, A; Kassouf, W; O'Flaherty, A; Tanguay, S; Wissing, MD, 2023) |
" High-grade B-cell lymphoma, NOS (HGBL) have an aggressive clinical behavior and poor outcome using regimens currently employed for diffuse large B-cell lymphoma (DLBCL) such as rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP)." | 3.88 | Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma. ( Bocchia, M; Cencini, E; Fabbri, A; Gentili, F; Mazzei, MA; Schiattone, L, 2018) |
"Corticosterone and prednisone are suggested to have the potential of being harmless, in contrast to dexamethasone, without promoting cell proliferation or inhibiting cytotoxic activity of cisplatin, yet beneficial to bladder cancer patients via suppressing tumor invasion." | 3.80 | Differential regulation of bladder cancer growth by various glucocorticoids: corticosterone and prednisone inhibit cell invasion without promoting cell proliferation or reducing cisplatin cytotoxicity. ( Ishiguro, H; Kashiwagi, E; Kawahara, T; Li, Y; Miyamoto, H; Zheng, Y, 2014) |
"Twenty patients with primary invasive bladder cancer who underwent radical cystectomy received postoperative adjuvant chemotherapy using a CAP (cyclophosphamide, doxorubicin and cisplatin) or modified M-VAC (methotrexate, vinblastine, pirarubicin and cisplatin) regimen." | 2.39 | [Neoadjuvant and adjuvant chemotherapy of bladder cancer]. ( Kotake, T; Kuroda, M, 1994) |
"To evaluate the incidence, diagnosis and treatment of immune-related adverse events (e-irAE) of checkpoint inhibition (ICI) in metastatic urothelial carcinoma (mUC) and metastatic renal cell carcinoma (mRCC)." | 1.91 | Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors. ( Burger, M; Büttner, R; Oppolzer, IA; Riester, J; Schnabel, MJ, 2023) |
"Eosinophilic cystitis is a rare and uncommon inflammatory bladder disease, in which the pathophysiology is unclear; only a few cases of such disease induced by intravesical instillations have been described." | 1.34 | Eosinophilic cystitis induced by bacillus Calmette-Guerin (BCG) intravesical instillation. ( Ben Sorba, N; Hidoussi, A; Jaidane, M; Mosbah, AF; Slama, A; Youssef, A; Zakhama, W, 2007) |
"Hematuria is the most common symptom in bladder lymphoma, outlet obstruction in prostate lymphoma." | 1.29 | [Non-Hodgkin's lymphoma with primary localization in the bladder and prostate region. Description of a case]. ( Gallmetzer, J; Mahlknecht, A, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (25.64) | 18.7374 |
1990's | 11 (28.21) | 18.2507 |
2000's | 8 (20.51) | 29.6817 |
2010's | 8 (20.51) | 24.3611 |
2020's | 2 (5.13) | 2.80 |
Authors | Studies |
---|---|
Oppolzer, IA | 1 |
Riester, J | 1 |
Büttner, R | 1 |
Burger, M | 1 |
Schnabel, MJ | 1 |
Wissing, MD | 1 |
O'Flaherty, A | 1 |
Dragomir, A | 1 |
Tanguay, S | 1 |
Kassouf, W | 1 |
Aprikian, AG | 1 |
Garje, R | 1 |
Chau, JJ | 1 |
Chung, J | 1 |
Wanat, K | 1 |
Zakharia, Y | 1 |
Cencini, E | 1 |
Fabbri, A | 1 |
Schiattone, L | 1 |
Gentili, F | 1 |
Mazzei, MA | 1 |
Bocchia, M | 1 |
Goto, D | 1 |
Otani, T | 1 |
Tomioka, A | 1 |
Maruyama, Y | 1 |
Mahfoud, T | 1 |
Tanz, R | 1 |
Mesmoudi, M | 1 |
Khmamouche, MR | 1 |
El Khannoussi, B | 1 |
Ichou, M | 1 |
Errihani, H | 2 |
Ishiguro, H | 1 |
Kawahara, T | 1 |
Zheng, Y | 1 |
Kashiwagi, E | 1 |
Li, Y | 1 |
Miyamoto, H | 1 |
Statoua, M | 1 |
Mokrim, M | 1 |
El Ghanmi, J | 1 |
Karmouni, T | 1 |
El Khadir, K | 1 |
Koutani, A | 1 |
Attya, AI | 1 |
Rowbottom, L | 1 |
Stinson, J | 1 |
McDonald, R | 1 |
Emmenegger, U | 1 |
Cheng, S | 1 |
Lowe, J | 1 |
Giotis, A | 1 |
Cheon, P | 1 |
Chow, R | 1 |
Pasetka, M | 1 |
Thavarajah, N | 1 |
Pulenzas, N | 1 |
Chow, E | 1 |
DeAngelis, C | 1 |
Kim, TK | 1 |
Xu, ML | 1 |
Podoltsev, NA | 1 |
Prebet, T | 1 |
Barbarotta, L | 1 |
Amin, K | 1 |
Kasberg, S | 1 |
Roche, K | 1 |
Stahl, M | 1 |
Gore, SD | 1 |
Zeidan, AM | 1 |
Hayashi, A | 1 |
Miyakawa, Y | 1 |
Bokuda, K | 1 |
Kimura, T | 1 |
Nakashima, E | 1 |
Irie, R | 1 |
Sugiura, H | 1 |
Suzuki, T | 1 |
Ohsone, Y | 1 |
Akizuki, S | 1 |
Oh, KC | 1 |
Zang, DY | 1 |
CONKLIN, EF | 1 |
Koike, H | 1 |
Morita, T | 1 |
Tamura, Y | 1 |
Kennedy, SE | 1 |
Shrikanth, S | 1 |
Charlesworth, JA | 1 |
Yokoyama, M | 1 |
Kobayashi, T | 1 |
Kubo, Y | 1 |
Kageyama, Y | 1 |
Kihara, K | 1 |
Schultz, A | 1 |
Maruschke, M | 1 |
Leithäuser, M | 1 |
Seiter, H | 1 |
Berger, A | 1 |
Kim, C | 1 |
Hagstrom, N | 1 |
Ferrer, F | 1 |
Hidoussi, A | 1 |
Slama, A | 1 |
Jaidane, M | 1 |
Zakhama, W | 1 |
Youssef, A | 1 |
Ben Sorba, N | 1 |
Mosbah, AF | 1 |
Sekine, H | 1 |
Fukui, I | 1 |
Yamada, T | 1 |
Takeuchi, S | 1 |
Tachibana, Y | 1 |
Yokokawa, M | 1 |
McLaughlin, TC | 1 |
Kaufmann, B | 1 |
Wegmann, W | 1 |
Mahlknecht, A | 1 |
Gallmetzer, J | 1 |
Millard, RJ | 1 |
McCredie, S | 1 |
Kuroda, M | 1 |
Kotake, T | 1 |
Ueda, T | 1 |
Yamauchi, T | 1 |
Kageyama, S | 1 |
Tsuzuki, M | 1 |
Kawakami, S | 1 |
Yonese, J | 1 |
Kawai, T | 1 |
Izes, JK | 1 |
Bihrle, W | 1 |
Thomas, CB | 1 |
Papadopoulos, AJ | 1 |
Pambakian, H | 1 |
Tiptaft, R | 1 |
Devaja, O | 1 |
Raju, KS | 1 |
Wittes, R | 1 |
Klotz, L | 1 |
Kosecka, U | 1 |
Hibino, S | 1 |
Stoller, RG | 1 |
Jacobs, SA | 1 |
Molina, JM | 1 |
Rabian, C | 1 |
D'Agay, MF | 1 |
Modai, J | 1 |
Melekos, MD | 1 |
Matsouka, P | 1 |
Fokaefs, E | 1 |
Pantazakos, A | 1 |
Repanti, M | 1 |
Tosaka, A | 1 |
Yamazaki, A | 1 |
Hirokawa, M | 1 |
Matsushita, K | 1 |
Asakura, S | 1 |
Merino Moreno, J | 1 |
Núñez Olarte, JM | 1 |
Picó Sambucety, JM | 1 |
Pastor Gómez-Cornejo, L | 1 |
Ortega Núñez, A | 1 |
Mitchell, ML | 1 |
Ernesti, M | 1 |
Raben, MS | 1 |
Scaliter, H | 1 |
Krain, LS | 1 |
Bierman, SM | 1 |
Biggs, AW | 1 |
Watkins, WE | 1 |
Kozak, JA | 1 |
Flanagan, MJ | 1 |
Goldstein, AG | 1 |
D'Escrivan, JC | 1 |
Allen, SD | 1 |
4 reviews available for prednisone and Bladder Cancer
Article | Year |
---|---|
Primary non-Hodgkin's lymphoma of the bladder: case report and literature review.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2013 |
[Neoadjuvant and adjuvant chemotherapy of bladder cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; | 1994 |
Corticosteroid-associated fatal mycobacterial sepsis occurring 3 years after instillation of intravesical bacillus Calmette-Guerin.
Topics: Administration, Intravesical; Aged; BCG Vaccine; Fatal Outcome; Humans; Male; Mycobacterium bovis; P | 1993 |
[A bulky mass non-Hodgkin's lymphoma with dysuria in the rectovesical space].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphom | 1990 |
35 other studies available for prednisone and Bladder Cancer
Article | Year |
---|---|
Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors.
Topics: Antineoplastic Agents, Immunological; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Humans; H | 2023 |
Chronic prednisone, metformin, and nonsteroidal anti-inflammatory drug use and clinical outcome in a cohort of bladder cancer patients undergoing radical cystectomy in Québec, Canada.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Canada; Cystectomy; Disease-Free Survival; Humans; Metformi | 2023 |
Acute Flare of Bullous Pemphigus With Pembrolizumab Used for Treatment of Metastatic Urothelial Cancer.
Topics: Acute Disease; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Disease Prog | 2018 |
Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Humans | 2018 |
[Case of primary malignant lymphoma of the bladder].
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Prot | 2013 |
Differential regulation of bladder cancer growth by various glucocorticoids: corticosterone and prednisone inhibit cell invasion without promoting cell proliferation or reducing cisplatin cytotoxicity.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Cispl | 2014 |
[Primary lymphoma of the bladder: a case report].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2014 |
Retrospective review of the incidence of monitoring blood glucose levels in patients receiving corticosteroids with systemic anticancer therapy.
Topics: Aged; Antineoplastic Agents; Blood Glucose; Comorbidity; Dexamethasone; Diabetes Complications; Diab | 2015 |
Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia.
Topics: Aged, 80 and over; Antibodies, Bispecific; Antineoplastic Agents; Antineoplastic Combined Chemothera | 2016 |
Primary diffuse large B-cell lymphoma of the bladder.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; | 2009 |
Primary non-Hodgkin's lymphoma of the bladder with bone marrow involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Marrow; Bone Neoplasms; | 2003 |
SOME UNUSUAL COMPLICATIONS OF METASTATIC CARCINOMA OF THE BREAST.
Topics: Breast Neoplasms; Esophageal Diseases; Esophageal Neoplasms; Esophageal Stenosis; Gastrointestinal H | 1964 |
[Primary malignant lymphoma of the urinary bladder: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; D | 2004 |
Acute granulomatous tubulointerstitial nephritis caused by intravesical BCG.
Topics: Acute Disease; Administration, Intravesical; Aged; BCG Vaccine; Biopsy, Needle; Carcinoma, Transitio | 2006 |
[A case of secondary malignant lymphoma of the urinary bladder].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 2006 |
[Genitourinary manifestations of lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Diagnosis, Different | 2007 |
Successful preoperative treatment of pediatric bladder inflammatory myofibroblastic tumor with anti-inflammatory therapy.
Topics: Antineoplastic Agents, Hormonal; Child, Preschool; Cyclooxygenase 2 Inhibitors; Humans; Inflammation | 2007 |
Eosinophilic cystitis induced by bacillus Calmette-Guerin (BCG) intravesical instillation.
Topics: Administration, Intravesical; Aged; Anti-Inflammatory Agents; BCG Vaccine; Carcinoma, Transitional C | 2007 |
[Combination chemotherapy with bleomycin, vinca alkaloid and cisplatin (BVP) for advanced urothelial cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Transitional Cell; Drug | 1984 |
Crohn's disease developing in an ileal conduit.
Topics: Crohn Disease; Humans; Ileostomy; Male; Middle Aged; Prednisone; Urinary Bladder Neoplasms; Urinary | 1981 |
[Bladder cancer and malignant melanoma following Endoxan therapy of a lymphoproliferative disease].
Topics: Adenoma; Carcinoma, Squamous Cell; Cervix Uteri; Cyclophosphamide; Drug Therapy, Combination; Female | 1981 |
[Non-Hodgkin's lymphoma with primary localization in the bladder and prostate region. Description of a case].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hematuria; Humans; Ly | 1995 |
Bladder cancer in patients on low-dose methotrexate and corticosteroids.
Topics: Adult; Carcinoma, Transitional Cell; Drug Therapy, Combination; Female; Humans; Methotrexate; Middle | 1994 |
[Primary malignant lymphoma of the urinary bladder achieving complete response by COMPA intraarterial chemotherapy: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; | 1994 |
Caecocystoplasty and bilateral oophorectomy followed by chemotherapy for diffuse, non-Hodgkins lymphoma of the ovary involving the bladder. Case report.
Topics: Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Cecum; Chemotherapy, Adjuvant | 1997 |
Severe bacillus Calmette-Guerin cystitis responds to systemic steroids when antituberculous drugs and local steroids fail.
Topics: Adjuvants, Immunologic; Aged; Anti-Inflammatory Agents; Antitubercular Agents; BCG Vaccine; Cystitis | 1999 |
Autoimmune haemolytic anaemia associated with transitional cell carcinoma.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Carcinoma, Transitional Cell; Humans; Male; Prednisone; Urinary | 1992 |
Hypersensitivity systemic reaction following intravesical bacillus Calmette-Guerin: successful treatment with steroids.
Topics: Administration, Intravesical; Adult; Alveolitis, Extrinsic Allergic; BCG Vaccine; Granuloma, Giant C | 1992 |
Primary non-Hodgkin's lymphoma of the urinary bladder.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; D | 1992 |
[Granulocytic sarcoma (chloroma) with bladder and breast localizations preceding acute myeloblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Drug | 1987 |
Control of hypoglycemia with diazoxide and hormones.
Topics: Adenoma, Islet Cell; Adrenocorticotropic Hormone; Aged; Benzothiadiazines; Blood Glucose; Diazoxide; | 1968 |
Pemphigus vulgaris and internal malignancy.
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Breast Neoplasms; Carcinoma, Squamous Cell; Dexamethasone; F | 1974 |
Carcinoma of the bladder in a renal transplant patient.
Topics: Azathioprine; Carcinoma, Transitional Cell; Cystoscopy; Kidney Transplantation; Prednisone; Transpla | 1973 |
Severe pancytopenia associated with the use of intravesical thio-TEPA.
Topics: Aged; Anemia, Aplastic; Carcinoma, Transitional Cell; Humans; Leukocyte Count; Male; Neoplasm Recurr | 1967 |
Haemorrhagic radiation cystitis.
Topics: Aged; Blood Transfusion; Cautery; Cobalt Isotopes; Cystitis; Female; Hematuria; Hemostasis; Humans; | 1968 |